Literature DB >> 17897321

Human adenovirus modulates surfactant phospholipid trafficking.

Olga L Miakotina1, Diann M McCoy, Lei Shi, Dwight C Look, Rama K Mallampalli.   

Abstract

Surfactant, highly enriched with phosphatidylcholine (PC), is secreted into the airspace by a classic apical secretory route, thereby maintaining lung stability. Herein, we show that adenoviral infection decreases surfactant PC in lungs by inhibiting its apical secretion and redirecting its export in alveolar cells by a basolateral route. These effects were not observed with replication-deficient adenovirus (Ad), specifically lacking early region 1 (E1) gene products. Adenoviral stimulation of basolateral PC export from cells was not observed after pharmacologic inhibition of ATP-binding cassette proteins, after introduction of small interfering RNA to the lipid pump ATP-binding cassette transporter A1 (ABCA1) or in ABCA1-defective human Tangier disease fibroblasts. Adenovirus and its E1A gene product increased ABCA1 levels by transcriptionally activating the ABCA1 gene. Thus, Ad lowers surfactant, in part, by triggering ABCA1-directed basolateral PC export, thereby limiting the cellular pool of surfactant PC destined for apical secretion. The results support a novel pathway, whereby a viral pathogen disrupts surfactant trafficking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897321     DOI: 10.1111/j.1600-0854.2007.00641.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  9 in total

1.  Calmodulin antagonizes a calcium-activated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis.

Authors:  Bill B Chen; Tiffany A Coon; Jennifer R Glasser; Rama K Mallampalli
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

Review 2.  Surfactant and its role in the pathobiology of pulmonary infection.

Authors:  Jennifer R Glasser; Rama K Mallampalli
Journal:  Microbes Infect       Date:  2011-09-10       Impact factor: 2.700

Review 3.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

Review 4.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

Review 5.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

Review 6.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

Review 7.  Lipid-based therapies against SARS-CoV-2 infection.

Authors:  Eman Humaid Alketbi; Rania Hamdy; Abdalla El-Kabalawy; Viktorija Juric; Marc Pignitter; Kareem A Mosa; Ahmed M Almehdi; Ali A El-Keblawy; Sameh S M Soliman
Journal:  Rev Med Virol       Date:  2021-01-13       Impact factor: 11.043

8.  Maternal and neonatal risk factors for neonatal respiratory distress syndrome in term neonates in Cyprus: a prospective case-control study.

Authors:  Paraskevi Stylianou-Riga; Theodora Boutsikou; Panayiotis Kouis; Paraskevi Kinni; Marina Krokou; Andriani Ioannou; Tania Siahanidou; Zoi Iliodromiti; Thalia Papadouri; Panayiotis K Yiallouros; Nicoletta Iacovidou
Journal:  Ital J Pediatr       Date:  2021-06-03       Impact factor: 2.638

9.  Sensitization of avian pathogenic Escherichia coli to amoxicillin in vitro and in vivo in the presence of surfactin.

Authors:  Jiaxu Liu; Xu Wang; Weiqi Shi; Zhuoyu Qian; Yongqiang Wang
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.